Winton Group’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.13M | Buy |
52,703
+1,882
| +4% | +$39.2K | 0.04% | 510 |
|
|
2025
Q4 | $1.09M | Sell |
50,821
-164,275
| -76% | -$3.37M | 0.04% | 454 |
|
|
2025
Q3 | $3.6M | Buy |
215,096
+136,820
| +175% | +$2.05M | 0.13% | 209 |
|
|
2025
Q2 | $1.12M | Sell |
78,276
-6,760
| -8% | -$92.7K | 0.06% | 395 |
|
|
2025
Q1 | $1.23M | Sell |
85,036
-4,945
| -5% | -$70.2K | 0.08% | 264 |
|
|
2024
Q4 | $1.18M | Sell |
89,981
-18,705
| -17% | -$258K | 0.08% | 236 |
|
|
2024
Q3 | $1.26M | Sell |
108,686
-21,805
| -17% | -$206K | 0.09% | 187 |
|
|
2024
Q2 | $985K | Buy |
130,491
+33,057
| +34% | +$273K | 0.07% | 248 |
|
|
2024
Q1 | $977K | Buy |
97,434
+51,700
| +113% | +$481K | 0.07% | 273 |
|
|
2023
Q4 | $425K | Buy |
45,734
+15,089
| +49% | +$156K | 0.03% | 400 |
|
|
2023
Q3 | $389K | Sell |
30,645
-643
| -2% | -$8.82K | 0.03% | 384 |
|
|
2023
Q2 | $445K | Sell |
31,288
-7,729
| -20% | -$109K | 0.04% | 377 |
|
|
2023
Q1 | $582K | Buy |
39,017
+13,757
| +54% | +$208K | 0.04% | 636 |
|
|
2022
Q4 | $375K | Buy |
25,260
+9,380
| +59% | +$153K | 0.02% | 727 |
|
|
2022
Q3 | $262K | Buy |
+15,880
| New | +$320K | 0.02% | 832 |
|
|
2022
Q2 | – | Sell |
-23,420
| Closed | -$550K | – | 1027 |
|
|
2022
Q1 | $550K | Buy |
+23,420
| New | +$573K | 0.03% | 650 |
|
|
2021
Q4 | – | Sell |
-53,121
| Closed | -$1.51M | – | 1249 |
|
|
2021
Q3 | $1.51M | Sell |
53,121
-57,250
| -52% | -$1.74M | 0.08% | 304 |
|
|
2021
Q2 | $3.33M | Buy |
110,371
+9,818
| +10% | +$290K | 0.18% | 65 |
|
|
2021
Q1 | $2.56M | Buy |
100,553
+22,493
| +29% | +$576K | 0.15% | 81 |
|
|
2020
Q4 | $1.92M | Sell |
78,060
-94,176
| -55% | -$1.77M | 0.14% | 124 |
|
|
2020
Q3 | $2.8M | Buy |
172,236
+28,214
| +20% | +$525K | 0.09% | 365 |
|
|
2020
Q2 | $2.46M | Sell |
144,022
-36,626
| -20% | -$543K | 0.06% | 548 |
|
|
2020
Q1 | $2.1M | Buy |
180,648
+23,083
| +15% | +$476K | 0.06% | 558 |
|
|
2019
Q4 | $4.38M | Sell |
157,565
-668,048
| -81% | -$16.8M | 0.06% | 517 |
|
|
2019
Q3 | $18.7M | Buy |
825,613
+23,201
| +3% | +$529K | 0.22% | 141 |
|
|
2019
Q2 | $20.2M | Buy |
802,412
+355,681
| +80% | +$9.55M | 0.39% | 97 |
|
|
2019
Q1 | $12.1M | Buy |
446,731
+16,267
| +4% | +$545K | 0.24% | 157 |
|
|
2018
Q4 | $14.2M | Buy |
430,464
+384,944
| +846% | +$15.5M | 0.31% | 123 |
|
|
2018
Q3 | $2.12M | Buy |
+45,520
| New | +$2.09M | 0.04% | 302 |
|
|
2015
Q1 | – | Sell |
-14,018
| Closed | -$927K | – | 482 |
|
|
2014
Q4 | $927K | Sell |
14,018
-31,874
| -69% | -$1.95M | 0.01% | 463 |
|
|
2014
Q3 | $2.52M | Buy |
45,892
+3,439
| +8% | +$195K | 0.02% | 423 |
|
|
2014
Q2 | $2.47M | Buy |
+42,453
| New | +$2.5M | 0.02% | 432 |
|
Other funds holding MD
VPM
VCM
WA
Winton Group's MD Position: Q1 2026 in Review
Winton Group increased its Pediatrix Medical (MD) stake by 3.7% in Q1 2026, buying an estimated $39.2K and bringing the position to 52,703 shares worth $1.13M. The position accounts for 0.04% of the portfolio, ranked #510.
Winton Group first reported a position in MD in Q2 2014 and has held it in 32 quarters since. The position peaked at $20.2M in Q2 2019. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- Winton Group held 52,703 shares of Pediatrix Medical worth $1.13M as of Q1 2026.
- Winton Group bought 1,882 Pediatrix Medical shares in Q1 2026, an estimated $39.2K.
- Pediatrix Medical made up 0.04% of Winton Group's portfolio in Q1 2026, its #510 holding.
- Winton Group first reported a position in Pediatrix Medical in Q2 2014 and has held it in 32 quarters since.
- Winton Group's Pediatrix Medical position peaked at $20.2M in Q2 2019.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.